With valuations growing across the stock market and the biopharma sector, it's only natural for value-sensitive investors to ...

The activist investment firm Starboard Value has launched a proxy fight again Pfizer, questioning the company’s management ...

Pfizer's Hympavzi receives FDA approval as the first anti-TFPI therapy for hemophilia A and B. This subcutaneous, once-weekly ...

A 54-year-old man from Omagh says his life has been completely devastated by side effects of the Pfizer Covid booster vaccine ...

AbbVie has been reporting an earnings decline because its former lead drug, Humira, lost patent-protected market exclusivity ...

Barely three years since its coronavirus vaccine helped stem the pandemic, Pfizer’s stock has lost 50 percent of its value ...

Robert F. Kennedy, Jr. has been antivax for two decades. His fellow travelers are not happy about his leaving out vaccines in ...

Since its inception in 1992, the FDA’s accelerated approval pathway has helped shepherd nearly 300 new drugs to the market.

Mr Lowe said that while he was not opposed to vaccines, his life had been destroyed. The Public Health Agency (PHA) said the ...

We recently compiled a list of the 10 Most Profitable NASDAQ Stocks To Invest In. In this article, we are going to take a ...

A program to accelerate drug trials often provides the market with new drugs that are only marginally more effective, but ...

Chronic stress speeds colorectal cancer's spread dramatically by disrupting gut microbiota -- the delicate balance of good ...